30 Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of longª²term administration of antioxidants on the development of retinopathy. Diabetes 2001;50(8):1938ª²1942

31 Haskins K, Bradley B, Powers K, et al. Oxidative stress in type 1 diabetes. Ann N Y Acad Sci 2003;1005:43ª²54

32 Takamura Y, Tomomatsu T, Kubo E, et al. Role of the polyol pathway in high glucoseª²induced apoptosis of retinal pericytes and proliferation of endothelial cells. Invest Ophthalmol Vis Sci 2008;49(7):3216ª²3223

33 Kowluru RA. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions. Life Sci 2005;76(9):1051ª²1060

34 Du XL, Edelstein D, Rossetti L, et al. Hyperglycemiainduced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitorª²1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 2000;97(22):12222ª²12226

35 Ha WJ, Yan H. The role of inflammationin diabetic retinopathy. Int J Ophthalmol(Guoji Yanke Zazhi) 2005;5(4):745ª²749

36 Miyamoto K, Khosrof S, Bursell SE, et al. Prevention of leukostasis and vascular leakage in streptozotocinª²induced diabetic retinopathy via intercellular adhesion moleculeª²1 inhibition. Proc Natl Acad Sci USA 1999;96(19):10836ª²10841

37 Boeri D, Maiello M, Lorenzi M. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes 2001;50(6):1432ª²1439

38 Kowluru RA, Koppolu P, Chakrabarti S, et al. Diabetesª²induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radical Research 2003;37(11):1169ª²1180

39 Zheng L, Szab¨® C, Kern TS. Poly(ADPª²ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factorª²kappaB. Diabetes 2004;53(11):2960ª²2967

40 Zheng L, Du Y, Miller C, et al. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocinª²induced diabetes. Diabetologia 2007;50(9):1987ª²1996

41 Ayalasomayajula SP, Amrite AC, Kompella UB. Inhibition of cyclooxygenaseª²2, but not cyclooxygenaseª²1, reduces prostaglandin E2 secretion from diabetic rat retinas. Eur J Pharmacol 2004;498(1ª²3):275ª²278

42 Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal antiª²inflammatory drugs prevent early diabetic retinopathy via TNFª²alpha suppresª²sion. FASEB J 2002;16(3):438ª² 440

43 Zhang XL, Qiu SD, Chen YJ, et al. An overview of the pathogenesis of diabetic retinopathy. Int J Ophthalmol(Guoji Yanke Zazhi) 2005;5(6):1239ª²1241

44 Li H, Hu XL. Role of vascular endothelial growth factor in the progress of diabetic retinopathy. Int J Ophthalmol(Guoji Yanke Zazhi) 2008;8(5):990ª²993

45 Poulaki V, Joussen AM, Mitsiades N, et al. Insulinª²like growth factorª²I plays a pathogenetic role in diabetic retinopathy. Am J Pathol 2004;165(2):457ª² 469

46 Meyerª²Schwickerath R, Pfeiffer A, Blum WF, et al. Vitreous levels of the insulinª²like growth factors I and II, and the insulinª²like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest 1993;92(6):2620ª²2625

47 Liu H, Ren JG, Cooper WL, et al. Identification of the antivasopermeability effect of pigment epitheliumª²derived factor and its active site. Proc Natl Acad Sci USA 2004;101(17):6605ª² 6610

48 Dawson DW, Volpert OV, Gillis P, et al. Pigment epitheliumª²derived factor: a potent inhibitor of angiogenesis. Science 1999;285(5425):245ª²248

49 Li Y, Lu Y. Perspectivers mechanism of diabetic retinopathy in early stage. Int J Ophthalmol(Guoji Yanke Zazhi) 2005;5(4):750ª²754

50 Chen Y, Zhu XH. The pathologic mechanism of diabetic retinopathy. Int J Ophthalmol(Guoji Yanke Zazhi) 2006;6(2):433ª² 435

ÉÏÒ»Ò³  [1] [2] [3] [4] [5]